Nicholas Berry

berry consultants llc

H指数:12

被引数:1,570

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma

GBM AGILE更新：一项全球性、II/III期自适应平台试验，旨在评估新诊断和复发性胶质母细胞瘤中的多种治疗方案

NEURO-ONCOLOGY

IF13.4

2025-11-010

OAAI

EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

PAXALISIB在新诊断和复发胶质母细胞瘤的GBM敏捷3期注册平台试验中的评估

NEURO-ONCOLOGY

IF13.4

2024-11-110

PRE

Mellinghoff, Ingo K.; Cloughesy, Timothy; Alexander, Brian; Berry, Donald A.; Buxton, Meredith; Cavenee, Webster; Colman, Howard; de Groot, John; Ellingson, Benjamin M.; Gordon, Gary B.; Lassman, Andrew B.; Lim, Michael; Khasraw, Mustafa; Perry, James; Sulman, Erik P.; Weller, Michael; Wen, Patrick; Yung, W. K. Alfred; Berry, Nicholas; Graves, Todd; Detry, Michelle; Hyddmark, E. M. Viktoria; Johnsson, Adam; Kling, Heather; Mcglothlin, Anna; Powell, Ashley; Untch, Sarah; Aquilanti, Elisa; Blondin, Nicholas; Boulmay, Brian; de la Fuente, Macarena; Drappatz, Jan; Jordan, Justin; Kaley, Thomas J.; Lobbous, Mina; Mikkelsen, Tom; Newton, Herbert; Owen, Scott; Peters, Katherine; Schiff, David; Sherman, Wendy; Weathers, Shiao-Pei; Youssef, Michael; Friend, John; Lee, Eudocia

UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

GBM AGILE的更新: 一项全球2/3期适应性平台试验，用于评估新诊断和复发性胶质母细胞瘤的多种治疗方案

NEURO-ONCOLOGY

IF13.4

2024-11-110

PRE

Lassman, Andrew; Alexander, Brian; Berry, Donald; Berry, Nicholas; Buxton, Meredith; Colman, Howard; Gan, Hui; de Groot, John; de la Fuente, Macarena; Drappatz, Jan; Ducray, Francois; Ellingson, Benjamin; Gordon, Gary; Hyddmark, Emma; Johnson, Adam; Khasraw, Mustafa; Lee, Eudocia; Lim, Michael; Mcglothlin, Anna; Mellinghoff, Ingo; Mikkelsen, Tom; Nghiemphu, Phioanh; Perry, James; Powell, Ashley; Sulman, Erik; Tanner, Krik; Untch, Sarah; Weller, Michael; Wen, Patrick; Wick, Antje; Yung, Alfred; Cloughesy, Timothy

Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

JOURNAL OF INFECTION

IF11.9

2024-10-010

OAAI

Hobbs, F. D. Richard; Gbinigie-Thompson, Oghenekome A.; Shanyinde, Milensu; Yu, Ly-Mee; Harris, Victoria; Dorward, Jienchi; Hayward, Gail; Saville, Benjamin R.; Berry, Nicholas S.; Evans, Philip H.; Thomas, Nicholas P. B.; Patel, Mahendra G.; Richards, Duncan; Van Hecke, Oliver; Detry, Michelle A.; Saunders, Christina T.; Fitzgerald, Mark; Robinson, Jared; Latimer-Bell, Charlotte; Allen, Julie; Ogburn, Emma; Grabey, Jenna; de Lusignan, Simon; Andersson, Monique; Little, Paul; Butler, Christopher C.

Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

伊维菌素用于社区成人新型冠状病毒肺炎 (原则): 一项开放、随机、对照、适应性的短期和长期结果平台试验

JOURNAL OF INFECTION

IF11.9

2024-04-015

OAAI

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

LANCET

IF88.5

2023-01-01237

OAAI

Butler, Christopher C.; Hobbs, F. D. Richard; Gbinigie, Oghenekome A.; Rahman, Najib M.; Hayward, Gail; Richards, Duncan B.; Dorward, Jienchi; Lowe, David M.; Standing, Joseph F.; Breuer, Judith; Khoo, Saye; Petrou, Stavros; Hood, Kerenza; Nguyen-Van-Tam, Jonathan S.; Patel, Mahendra G.; Saville, Benjamin R.; Marion, Joe; Ogburn, Emma; Allen, Julie; Rutter, Heather; Francis, Nick; Thomas, Nicholas P. B.; Evans, Philip; Dobson, Melissa; Madden, Tracie-Ann; Holmes, Jane; Harris, Victoria; Png, May Ee; Lown, Mark; van Hecke, Oliver; Detry, Michelle A.; Saunders, Christina T.; Fitzgerald, Mark; Berry, Nicholas S.; Mwandigha, Lazaro; Galal, Ushma; Mort, Sam; Jani, Bhautesh D.; Hart, Nigel D.; Ahmed, Haroon; Butler, Daniel; McKenna, Micheal; Chalk, Jem; Lavallee, Layla; Hadley, Elizabeth; Cureton, Lucy; Benysek, Magdalena; Andersson, Monique; Coates, Maria; Barrett, Sarah; Bateman, Clare; Davies, Jennifer C.; Raymundo-Wood, Ivy; Ustianowski, Andrew; Carson-Stevens, Andrew; Yu, Ly-Mee; Little, Paul

Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial

BRITISH JOURNAL OF GENERAL PRACTICE

IF5.2

2022-03-2328

OAAI

Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

LANCET RESPIRATORY MEDICINE

IF32.8

2021-09-0155

OAAI

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

LANCET

IF88.5

2021-09-01157

OAAI

Yu, Ly-Mee; Bafadhel, Mona; Dorward, Jienchi; Hayward, Gail; Saville, Benjamin R.; Gbinigie, Oghenekome; Van Hecke, Oliver; Ogburn, Emma; Evans, Philip H.; Thomas, Nicholas P. B.; Patel, Mahendra G.; Richards, Duncan; Berry, Nicholas; Detry, Michelle A.; Saunders, Christina; Fitzgerald, Mark; Harris, Victoria; Shanyinde, Milensu; De Lusignan, Simon; Andersson, Monique I.; Barnes, Peter J.; Russell, Richard E. K.; Nicolau, Dan V., Jr.; Ramakrishnan, Sanjay; Hobbs, F. D. Richard; Butler, Christopher C.

Nicholas Berry

个人简介

教育背景

工作经历

荣誉奖项

研究方向